
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
| Open | 331.45 |
| High | 338.95 |
| Low | 316.30 |
| Prev Close | 331.40 |
| Volume | 7,76,389 |
| VWAP(₹) | 325.76 |
| PE Ratio(x) | 41.99 |
| EPS - TTM(₹) | 7.80 |
| MCap(₹ Cr.) | 1,366.55 |
| MCap Rank | 51 |
| PB Ratio(x) | 1.95 |
| Div Yield(%) | - |
| Face Value(₹) | 5.00 |
| 52W High(₹) | 718.00 |
| 52W Low(₹) | 198.05 |
| MCap/Sales | 2.64 |
| Beta(1 Month) | 1.75 |
| BV/Share(₹) | 168.81 |
Employee & Interest Expense
Company has spent 3.81% of its operating revenues towards interest expenses and 21.6% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)Increase in Cash from Investing
Company has used Rs 150.03 cr for investing activities which is an YoY increase of 776.41%. (Source: Consolidated Financials)Genesys Intnl Share Price Update
Genesys International Corporation Ltd. share price moved down by -1.69% from its previous close of Rs 331.40. Genesys International Corporation Ltd. stock last traded price is 325.80
| Share Price | Value |
|---|---|
| Today/Current/Last | 325.80 |
| Previous Day | 331.40 |
Found Insights useful?
| 1 Day | -1.69% |
| 1 Month | 49.28% |
| 3 Months | 20.09% |
| 1 Year | -52.23% |
| 3 Years | 2.04% |
| 5 Years | 175.05% |
1 Analysts
| Ratings | Current | 1W Ago | 1M Ago | 3M Ago |
|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 |
| Buy | - | - | - | - |
| Hold | - | - | - | - |
| Sell | - | - | - | - |
| Strong Sell | - | - | - | - |
| # Analysts | 1 | 1 | 1 | 1 |
Ahead of Market: 10 things that will decide stock market action on Tuesday
5 multibaggers from Ashish Kacholia's portfolio log blockbuster Q1 nos, PAT jumps up to 222%
Stock market update: Nifty Pharma index advances 0.23% in a weak market
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Associ..
Announcements| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | |
|---|---|---|---|---|---|
| Total Income | 107.67 | 86.90 | 80.79 | 72.14 | 94.27 |
| Total Income Growth (%) | 23.89 | 7.57 | 11.99 | -23.47 | 3.68 |
| Total Expenses | 87.22 | 81.94 | 62.57 | 56.80 | 59.67 |
| Total Expenses Growth (%) | 6.45 | 30.95 | 10.16 | -4.82 | -4.09 |
| EBIT | 20.44 | 4.97 | 18.22 | 15.34 | 34.60 |
| EBIT Growth (%) | 311.62 | -72.73 | 18.73 | -55.65 | 20.50 |
| Profit after Tax (PAT) | 12.36 | 1.09 | 12.00 | 7.12 | 18.95 |
| PAT Growth (%) | 1,030.98 | -90.89 | 68.57 | -62.43 | -8.31 |
| EBIT Margin (%) | 18.99 | 5.72 | 22.55 | 21.27 | 36.70 |
| Net Profit Margin (%) | 11.48 | 1.26 | 14.85 | 9.87 | 20.10 |
| Basic EPS (₹) | 3.04 | 0.25 | 2.89 | 1.75 | 4.77 |
All figures in Rs Cr, unless mentioned otherwise
Employee & Interest Expense
Company has spent 3.81% of its operating revenues towards interest expenses and 21.6% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)| Annual | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Total Assets | 972.43 | 777.97 | 634.60 | 505.62 | 321.37 |
| Total Assets Growth (%) | 25.00 | 22.59 | 25.51 | 57.33 | 5.68 |
| Total Liabilities | 266.98 | 220.88 | 143.82 | 98.13 | 85.49 |
| Total Liabilities Growth (%) | 20.87 | 53.58 | 46.56 | 14.78 | 73.90 |
| Total Equity | 705.45 | 557.08 | 490.78 | 407.49 | 235.87 |
| Total Equity Growth (%) | 26.63 | 13.51 | 20.44 | 72.76 | -7.48 |
| Current Ratio (x) | 2.62 | 2.41 | 3.04 | 3.52 | 1.73 |
| Total Debt to Equity (x) | 0.23 | 0.20 | 0.11 | 0.08 | 0.10 |
| Contingent Liabilities | 0.00 | 42.73 | 36.35 | 27.97 | 10.58 |
All figures in Rs Cr, unless mentioned otherwise
| Annual | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Net Cash flow from Operating Activities | 15.81 | -52.86 | 19.07 | -35.19 | 27.48 |
| Net Cash used in Investing Activities | -150.03 | -17.12 | -79.61 | -188.48 | -19.28 |
| Net Cash flow from Financing Activities | 138.76 | 50.49 | 71.24 | 214.86 | 11.91 |
| Net Cash Flow | 5.85 | -19.92 | 10.70 | -8.82 | 20.10 |
| Closing Cash & Cash Equivalent | 9.20 | 3.34 | 23.27 | 12.56 | 21.48 |
| Closing Cash & Cash Equivalent Growth (%) | 175.06 | -85.63 | 85.20 | -41.51 | 1,455.05 |
| Total Debt/ CFO (x) | 10.13 | -2.08 | 2.72 | -0.92 | 0.74 |
All figures in Rs Cr, unless mentioned otherwise
Cash from Operations vs PAT
Operating cash flow of Rs 15.81 cr is 0.49 times compared to the reported net profit of Rs 32.58 cr. (Source: Consolidated Financials)Increase in Cash from Investing
Company has used Rs 150.03 cr for investing activities which is an YoY increase of 776.41%. (Source: Consolidated Financials)| Annual | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Return on Equity (%) | 4.63 | 10.12 | 4.51 | 4.70 | 6.54 |
| Return on Capital Employed (%) | 8.77 | 15.53 | 7.81 | 6.33 | 4.76 |
| Return on Assets (%) | 3.34 | 7.22 | 3.47 | 3.77 | 4.17 |
| Interest Coverage Ratio (x) | 10.34 | 16.68 | 21.89 | 24.33 | 12.45 |
| Asset Turnover Ratio (x) | 0.37 | 0.44 | 0.35 | 0.44 | 0.42 |
| Price to Earnings (x) | 26.67 | 51.02 | 106.38 | 65.36 | 135.14 |
| Price to Book (x) | 1.23 | 5.16 | 4.78 | 3.06 | 8.73 |
| EV/EBITDA (x) | 7.17 | 20.18 | 27.03 | 19.40 | 58.93 |
| EBITDA Margin (%) | 39.36 | 47.09 | 43.16 | 35.81 | 25.78 |
Found Financials useful?
No Data Available
No Data Available
| R1 | - | Pivot - | S1 | - |
| R2 | - | S2 | - | |
| R3 | - | S3 | - |
| 5 Days | 14 Days | 28 Days |
| - | - | - |
Choose from Peers
Choose from Stocks
No Data Available
Board Meeting
Audited Results
May 22, 2026
General Meeting
-
Apr 30, 2026
Board Meeting
Increase in Authorised Capital & Others
Apr 20, 2026
| Announced on | Meeting on |
| May 22, 2026 | May 29, 2026 |
| Audited Results | |
| Apr 20, 2026 | Apr 23, 2026 |
| Increase in Authorised Capital & Others | |
| Feb 05, 2026 | Feb 12, 2026 |
| Quarterly Results | |
| Nov 06, 2025 | Nov 13, 2025 |
| Quarterly Results | |
| Aug 06, 2025 | Aug 13, 2025 |
| Quarterly Results | |
| Announced on | Ex-Date | Dividend% |
| May 22, 2019 | Sep 18, 2019 | 2% |
| May 31, 2018 | Sep 18, 2018 | 2% |
| Jun 01, 2017 | Sep 19, 2017 | 2% |
| May 31, 2016 | Sep 21, 2016 | 2% |
| Jun 01, 2015 | Sep 18, 2015 | 2% |
No Data Available
| Announced on | Ex-Date |
| Apr 29, 2010 | Jun 23, 2010 |
| Split: Old FV10.0| New FV:5.0 | |
No Data Available
| Announced on | Meeting on |
| Apr 30, 2026 | Jun 01, 2026 |
| - | |
| Sep 11, 2025 | Sep 30, 2025 |
| - | |
| Feb 18, 2025 | Mar 12, 2025 |
| - | |
| Jan 31, 2025 | Mar 05, 2025 |
| - | |
| Sep 19, 2024 | Sep 30, 2024 |
| A.G.M. | |
Genesys International Corporation Ltd., incorporated in the year 1983, is a Small Cap company (having a market cap of Rs 1,384.93 Crore) operating in IT Software sector.
Key Indices Listed On
BSE SmallCap, BSE Information Technology, BSE AllCap, BSE MidSmallCap
Address
73-A, SDF-III, SEEPZ,Andheri (East),Mumbai, Maharashtra - 400096
Sajid Malik
Chairman & Managing DirectorAjay Aggarwal
Independent DirectorBharti Sinha
Independent DirectorManish Patel
Independent DirectorDATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.